Hadasit Bio

HDST•TA

Healthcare Israel Biotechnology & Medical Research

Need professional-grade analysis? Visit stockanalysis.com

₪73.10

-0.14%

End of day

Market Cap

$13.90M

P/E Ratio

N/A

Employees

Dividend Yield

N/A

Price Chart

Risk-Adjusted Performance

Ratio	1W	1M	3M	6M	1Y	5Y	Score
Sortino	-2.73	—	—	—	—	—	-2.73
Calmar	-29.13	—	—	—	—	—	-29.13
Sharpe	-2.90	—	—	—	—	—	-2.90
Omega	0.00	—	—	—	—	—	0.00
Martin	-36.62	—	—	—	—	—	-36.62
Ulcer	2.01	—	—	—	—	—	2.01

Hadasit Bio (HDST) Price Performance

Hadasit Bio (HDST) trades on TA in ILS. The company is classified in the Healthcare sector under the Biotechnology & Medical Research industry. The stock currently trades at ILS73.10, down 0.14% from the previous close.

Over the past year, HDST has traded between a low of ILS28.10 and a high of ILS83.00. The stock has gained 78.3% over this period. It is currently 11.9% below its 52-week high.

Hadasit Bio has a market capitalization of $13.90M.

About Hadasit Bio

HBL - Hadasit Bio-Holdings Ltd operates in the biotechnology industry in Israel. It operates in the fields of oncology, regenerative medicine, and inflammatory disease. The company develops biological drugs; and plasma RNA biomarkers for colorectal cancer. It offers ProtAb, an immunotherapeutic monoclonal antibody for the treatment of autoimmune inflammatory diseases. HBL - Hadasit Bio-Holdings Ltd was incorporated in 2005 and is based in Jerusalem, Israel.

Company Info

Sector: Healthcare
Industry: Biotechnology & Medical Research
Exchange: TA
Currency: ILS
Country: Israel

Financial Metrics

Revenue (TTM): $-29,918,000
EBITDA: $-2,729,000
Profit Margin: N/A
EPS (TTM): -2.81
Book Value: 3.16

Technical Indicators

52 Week High: ₪85.00
52 Week Low: ₪28.10
50 Day MA: ₪106.65
200 Day MA: ₪147.11
Beta: 0.58

Valuation

Trailing P/E: N/A
Forward P/E: N/A
Price/Sales: 0.90
Price/Book: 0.52
Enterprise Value: $974,006